GENE ONLINE|News &
America’s Ongoing Battle For Lower Insulin Prices
The cost of healthcare in America is astronomical, and insulin prices are a heavy burden on millions of Americans each month. In March, the U.S. House of Representatives passed the Affordable Insulin Now Act to cap insulin prices for insured individuals to $35 a month. The bill appears optimistic for people with diabetes, but the text raises questions about who will actually benefit from lower insulin prices and who may have to pay the same as they have been.
